Supplement Forms/Alternate Names
• Natural progesterone, micronized progesterone, progesterone cream
Progesterone is one of two main female hormones. It has been used for pregnancy support and to ease symptoms of menopause. Progesterone can be used as an oil, extract, or cream. It can also be used as a nasal spray.Dosages
There are no advised doses for progesterone.
What Research Shows
May Not Be Effective
Not Enough Data to Assess
Editorial process and description of evidence categories can be found at EBSCO NAT Editorial Process.
It is likely safe to progesterone in small doses for a short time, but problems such as stomach upset, skin reactions, weight gain, and other side effects may happen. Not enough studies have been done to say whether it is safe to use for a long period or by women who are breastfeeding.
Talk to your doctor about any supplements or therapy you would like to use. Some can interfere with treatment or make conditions worse such as:
References [ + ]
A. Assisted Reproduction
A1. Liu XR, Mu HQ, et al. The optimal duration of progesterone supplementation in pregnant women after IVF/ICSI: a meta-analysis. Reprod Biol Endocrinol. 2012 Dec 13;10:107.
A2. Hill MJ, Whitcomb BW, et al. Progesterone luteal support after ovulation induction and intrauterine insemination: a systematic review and meta-analysis. Fertil Steril. 2013 Nov;100(5):1373-1380.
A3. van der Linden M, Buckingham K, et al. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev. 2015 Jul 7;(7):CD009154.
B. Miscarriage Prevention
B1. Lim CE, Ho KK, et al. Combined oestrogen and progesterone for preventing miscarriage. Cochrane Database Syst Rev. 2013;(9):CD009278.
B2. Coomarasamy A, Williams H, et al. A Randomized Trial of Progesterone in Women with Recurrent Miscarriages. N Engl J Med. 2015 Nov 26;373(22):2141-2148.
C. Pregnancy Support
C1. Oler E, Eke AC, et al. Meta-analysis of randomized controlled trials comparing 17α-hydroxyprogesterone caproate and vaginal progesterone for the prevention of recurrent spontaneous preterm delivery. Int J Gynaecol Obstet. 2017;138(1):12-16.
C2. Jarde A, Lustiv O, et al. Vaginal progesterone, oral progesterone, 17-OHPC, cerclage, and pessary for preventing preterm birth in at-risk singleton pregnancies: an updated systematic review and network meta-analysis. BJOG. 2019;126(5):556-567.
D. Premenstrual Syndrome
D1. Ford O, Lethaby A, et al. Progesterone for premenstrual syndrome. Cochrane Database Syst Rev. 2012;(3):CD003415.
E. Traumatic Brain Injury
E1. Ma J, Huang S, et al. Progesterone for acute traumatic brain injury. Cochrane Database Syst Rev. 2016;12:CD008409.
E2. Pan ZY, Zhao YH, et al. Effect of progesterone administration on the prognosis of patients with severe traumatic brain injury: a meta-analysis of randomized clinical trials. Drug Des Devel Ther. 2019;13:265-273.
Last reviewed December 2015 by EBSCO CAM Review Board